Sleep Aids in Australia
Demand for sleep aids continues to grow in 2022, supported by the lifting of COVID-19 restrictions in Australia. This scenario has seen local consumers returning to busy lifestyles with challenges to balance work and family obligations. Many workplaces requested that employees return to the office and whilst hybrid measures are still an option for many, the stress to find a workload/family balance is fuelling anxiety and sleep issues, thereby supporting further sales of sleep aids in 2022. Resea...
Euromonitor International's Sleep Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Sleep Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Sleep Aids in Australia
- Euromonitor International
- November 2022
- List Of Contents And Tables
- SLEEP AIDS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Growth boosted by the return to busier lifestyles amongst local population
- Growth in wellness-driven demand contributes to sales
- Switch of melatonin boosts demand from ageing population
- PROSPECTS AND OPPORTUNITIES
- Slower growth expected due to growing competition from natural options and alternative services
- New product development and innovation will strengthen consumer interest
- Ageing population expected to support growth of sleep aids in Australia
- CATEGORY DATA
- Table 1 Sales of Sleep Aids: Value 2017-2022
- Table 2 Sales of Sleep Aids: % Value Growth 2017-2022
- Table 3 NBO Company Shares of Sleep Aids: % Value 2018-2022
- Table 4 LBN Brand Shares of Sleep Aids: % Value 2019-2022
- Table 5 Forecast Sales of Sleep Aids: Value 2022-2027
- Table 6 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
- CONSUMER HEALTH IN AUSTRALIA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 8 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2017-2022
- Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 14 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 16 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources